Indications |
Oral Diabetic neuropathic oedema Adult: 30-60 mg tid. Child: Intravenous Reversal of spinal or epidural anaesthesia-induced hypotension Adult: 3-6 mg or up to 9 mg in a 3 mg/mL soln given as slow Inj repeated every 3-4 min, as needed. Max Dosage: 30 mg. |
Contraindications |
Hypersensitivity. Hypertension, thyrotoxicosis, BPH. Lactation. |
Warnings / Precautions |
Ischaemic heart disease, hyperthyroidism, diabetes mellitus, hypertension, angle-closure glaucoma, renal impairment; prostatic enlargement; pregnancy, elderly. |
Adverse Reactions |
Anxiety, tachycardia, tremor, dry mouth, hypertension, cardiac arrhythmias, impaired circulation to the extremities, nervousness, insomnia, palpitations. Difficulty in micturition in patients with prostatic enlargement. Nasal drops: Local irritation, rebound nasal congestion and drug-induced rhinitis on prolonged use. Potentially Fatal: Delusions, hallucinations. Seen with hypersensitivity and overdosage. Acute CNS and CVS stimulation presenting as vomiting, fever, hypertension, psychosis. Cardiac arrhythmias. |
Drug Interactions |
Reduces antihypertensive effect of bethanidine and guanethidine. May increase clearance of dexamethasone. Increased incidence of adverse effects when used with theophylline. Potentially Fatal: Severe HTN when combined with MAOIs or withi 2 wk of discontinuance of MAOI treatment. Increased risk of arrhythmias with cardiac glycosides, quinidine or tricyclic antidepressants. Increased vasoconstriction or pressor effects with ergot alkaloids or oxytocin. See Below for More ephedrine Drug Interactions |
Mechanism of Actions |
Ephedrine has both α- and β-adrenergic acitivity with pronounced stimulating effects on the CNS. It increases cardiac output, induces peripheral vasoconstriction, bronchodilation, reduces intestinal tone and motility, and relaxes the bladder while contracting the sphincter muscle. It also has stimulant action on the resp center and dilates the pupil witho affecting light reflexes. Absorption: Readily and completely absorbed form the GIT (oral). Metabolism: Hepatic. Excretion: Via urine (largely as unchanged, small amounts of metabolites); 3-6 hrs (elimination half-life). |
Administration |
May be taken with or without food. |
Storage Conditions |
Intravenous: Store at 15-25°C. Oral: Store at 15-25°C. |
ATC Classification |
R01AA03 - ephedrine ; Belongs to the class of topical sympathomimetic agents used as nasal decongestants. R01AB05 - ephedrine ; Belongs to the class of topical sympathomimetic combination preparations, excluding corticosteroids. Used as nasal decongestants. R03CA02 - ephedrine ; Belongs to the class of adrenergics for systemic use, alpha- and beta-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases. S01FB02 - ephedrine ; Belongs to the class of sympathomimetics used as mydriatics and cycloplegics. |
Storage |
Intravenous: Store at 15-25°C. Oral: Store at 15-25°C. |
Available As |
|
Ephedrine
Post Review about Ephedrine Click here to cancel reply.
Ephedrine Containing Brands
Ephedrine is used in following diseases
Drug - Drug Interactions of Ephedrine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.